Skip to main content
AS

Aston Sci

Aston Sci is a clinical-stage biopharmaceutical company developing therapeutic cancer vaccines targeting oncology, immunology, and geriatrics to address cancer recurrence and treatment-related side effects. Their focus on efficient clinical development aims to improve patient outcomes in the fight against cancer.

Traction 7/10
Seoul, South Korea · HQ
Founded 201881K+ followers
  • Biotechnology
Updated 7 months ago

Funding

Raised to date

$22.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Hun Jung

CEO

Product

Features

  • Aston Sci is a clinical-stage biopharmaceutical company developing therapeutic cancer vaccines targeting oncology, immunology, and geriatrics to address cancer recurrence and treatment-related side effects. Their focus on efficient clinical development aims to improve patient outcomes in the fight against cancer.
This profile is AI-generated and may contain inaccuracies.